Retatrutide is an investigational triple hormone receptor agonist, often referred to as a GLP-3 weight loss medication because it targets GLP-1, GIP, and glucagon receptors
Its important to note that most insurance plans do not cover lipotropic injections as they are considered elective treatments.
These Include Pancreatitis (Inflammation of the Pancreas), Vision Changes, Hypoglycemia (Low Blood Sugar), Kidney Problems, Intense Stomach Pain, Gallbladder Issues, and Allergic Reactions
The cost of labs may also vary if you are using insurance or paying out-of-pocket
A man who used Ozempic for weight loss found that using the GLP-1 medication had an unexpected impact on him after drinking alcohol
Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD